COVID-19 Vaccines and Herd Immunity

COVID-19 Vaccines and Herd Immunity

With coronavirus vaccines now available, what are the timeline and prospects for "herd immunity" and return to a new normal? Marc Lipsitch, DPhil, of Harvard T.H. Chan School of Public Health returns to JAMA's Q&A series with Paul D. Biddinger, MD, director of Massachusetts General Hospital's Center for Disaster Medicine, to discuss. Recorded December 17, 2020.

Related Article:

The Ethics of Continuing Placebo in SARS-CoV-2 Vaccine Trials

Jaksot(227)

The Winter COVID-19 Surge in New York and Los Angeles

The Winter COVID-19 Surge in New York and Los Angeles

Mitchell Katz, MD, president and chief executive officer of New York City Health + Hospitals, and former Los Angeles County health agency director, discusses causes, similarities, and differences betw...

15 Tammi 202110min

Coronavirus Vaccine Update With Arnold S. Monto, MD

Coronavirus Vaccine Update With Arnold S. Monto, MD

Arnold S. Monto, MD, chaired the US Food and Drug Administration's Vaccines and Related Biological Products Advisory Committee (VRBPAC) meetings in December that led to Emergency Use Authorization (EU...

13 Tammi 202130min

An Opportune Time to Update Medical Licensing

An Opportune Time to Update Medical Licensing

Interview with Samyukta Mullangi, MD, MBA, author of The COVID-19 Pandemic—An Opportune Time to Update Medical Licensing; also with Mitchell H. Katz, MD, chief executive officer of New York City Heal...

13 Tammi 202123min

Using Lorenz Curves to Measure Racial Inequities in COVID-19 Testing

Using Lorenz Curves to Measure Racial Inequities in COVID-19 Testing

Aaloke Mody, MD, joins JAMA Network Open Digital Media Editor, Seth Trueger, MD, MPH, to discuss a cross-sectional study that uses Lorenz curves as a metric for quantifying racial inequities in corona...

12 Tammi 202112min

Understanding the New SARS-CoV-2 Mutation Found in England

Understanding the New SARS-CoV-2 Mutation Found in England

Gregory Armstrong, MD, director of the Advanced Molecular Detection Program for the CDC, explains what is currently known about the new mutations of SARS-CoV-2. Related Article(s): Genetic Variants o...

8 Tammi 202113min

COVID-19 Vaccine Safety–Anaphylaxis and Allergic Reactions

COVID-19 Vaccine Safety–Anaphylaxis and Allergic Reactions

Tom Shimabukuro, MD, MPH, MBA, and Sara Mbaeyi, MD, MPH, from the CDC discuss rare allergic complications in patients who received the first dose of the Pfizer-BioNTech vaccine between December 14-23,...

6 Tammi 202116min

Understanding SARS-CoV-2 Genetic Variants

Understanding SARS-CoV-2 Genetic Variants

Adam Lauring, MD, PhD, from the University of Michigan Division of Infectious Diseases, an expert on the evolutionary biology of RNA viruses, explains the new genetic variants recently found in SARS-C...

6 Tammi 202140min

Public Concern About Violence, Firearms, and the COVID-19 Pandemic in California

Public Concern About Violence, Firearms, and the COVID-19 Pandemic in California

Nicole Kravitz-Wirtz, PhD, MPH, joins JAMA Network Open Digital Media Editor, Seth Trueger, MD, MPH, to discuss a survey study describing individuals' concerns regarding violence in the context of the...

5 Tammi 202112min

Suosittua kategoriassa Tiede

rss-mita-tulisi-tietaa
rss-poliisin-mieli
mielipaivakirja
rss-duodecim-lehti
utelias-mieli
tiedekulma-podcast
docemilia
university-of-eastern-finland
vinkista-vihia
rss-vaasan-yliopiston-podcastit
rss-duokkari-ekstra
rss-astetta-parempi-elama-podcast
rss-metsantuntijat-podcast
rss-tiedetta-vai-tarinaa
rss-ilmasto-kriisissa
rss-pandapodi
rss-luontopodi-samuel-glassar-tutkii-luonnon-ihmeita
rss-sosiopodi